{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:26:34Z","timestamp":1792121194178,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018503","name":"InfraRedx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018503","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015854","name":"Scott R. MacKenzie Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jcin.2021.06.020","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T16:01:09Z","timestamp":1627920069000},"page":"1688-1703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Antithrombotic Therapy After Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"14","author":[{"given":"Davide","family":"Capodanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurrien M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcin.2021.06.020_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jcin.2021.06.020_bib2","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib3","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2019.08.1032","article-title":"Thrombotic versus bleeding risk after transcatheter aortic valve replacement","volume":"74","author":"Mangieri","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jcin.2021.06.020_bib4","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","article-title":"ACC\/AHA versus ESC guidelines on dual antiplatelet therapy","volume":"72","author":"Capodanno","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jcin.2021.06.020_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jacc.2016.05.054","article-title":"Cerebral embolism","volume":"68","author":"Barth\u00e9l\u00e9my","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jcin.2021.06.020_bib6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.jcin.2021.06.020_bib7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.jcin.2021.06.020_bib8","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.jcin.2021.06.020_bib9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.jcin.2021.06.020_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2021.06.020_bib11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2021.06.020_bib12","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.jcin.2021.06.020_bib13","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis","volume":"65","author":"Thyregod","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jcin.2021.06.020_bib14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jcin.2019.06.019","article-title":"Impact of pre-existing and new-onset atrial fibrillation on outcomes after transcatheter aortic valve replacement","volume":"12","author":"Mentias","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"17","key":"10.1016\/j.jcin.2021.06.020_bib15","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","article-title":"Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following transcatheter aortic valve replacement","volume":"11","author":"Vora","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"5","key":"10.1016\/j.jcin.2021.06.020_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/anec.12345","article-title":"Type of atrial fibrillation and clinical outcomes in patients undergoing transcatheter aortic valve replacement","volume":"21","author":"Shaul","year":"2016","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"38","key":"10.1016\/j.jcin.2021.06.020_bib17","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","article-title":"Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis","volume":"40","author":"Siontis","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2021.06.020_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.02.098","article-title":"Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement","volume":"234","author":"J\u00f8rgensen","year":"2017","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.jcin.2021.06.020_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.jcin.2021.06.020_bib20","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.jcin.2016.07.024","article-title":"Neurological outcomes with embolic protection devices in patients undergoing transcatheter aortic valve replacement","volume":"9","author":"Giustino","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.06.020_bib21","unstructured":"Diaz VAJ. Short-course dual antiplatelet therapy versus oral anticoagulation to prevent cerebral embolism after transcatheter aortic valve replacement. Paper presented at: TCT 2019; September 28, 2019; San Francisco, CA."},{"issue":"7","key":"10.1016\/j.jcin.2021.06.020_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14779072.2019.1632189","article-title":"Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update","volume":"17","author":"Greco","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"24","key":"10.1016\/j.jcin.2021.06.020_bib23","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.jacc.2020.04.060","article-title":"Subclinical thrombosis of bioprosthetic aortic valves","volume":"75","author":"Giustino","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.jcin.2021.06.020_bib24","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.4244\/EIJV13I15A281","article-title":"Subclinical leaflet thrombosis\u2014a concern, but also an issue?","volume":"13","author":"S\u00f8ndergaard","year":"2018","journal-title":"EuroIntervention"},{"issue":"21","key":"10.1016\/j.jcin.2021.06.020_bib25","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jcin.2021.06.020_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcmg.2017.02.005","article-title":"Systematic CT methodology for the evaluation of subclinical leaflet thrombosis","volume":"10","author":"Jilaihawi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"24","key":"10.1016\/j.jcin.2021.06.020_bib27","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves","volume":"75","author":"Makkar","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10087","key":"10.1016\/j.jcin.2021.06.020_bib28","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"issue":"28","key":"10.1016\/j.jcin.2021.06.020_bib29","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/eurheartj\/ehx369","article-title":"Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves","volume":"38","author":"Sondergaard","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jcin.2021.06.020_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2021.06.020_bib31","unstructured":"Montalescot G. Apixaban and valve thrombosis after transcatheter aortic valve implantation: the ATLANTIS 4D-CT substudy. Presented at: ACC.21 Scientific Sessions. May 15, 2021; Virtual."},{"issue":"6","key":"10.1016\/j.jcin.2021.06.020_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcin.2020.01.227","article-title":"Chimney stenting for coronary occlusion during TAVR","volume":"13","author":"Mercanti","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"1","key":"10.1016\/j.jcin.2021.06.020_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4244\/EIJ-D-19-00056","article-title":"Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction. Part 1: how to evaluate patients for BASILICA","volume":"15","author":"Komatsu","year":"2019","journal-title":"EuroIntervention"},{"issue":"AB","key":"10.1016\/j.jcin.2021.06.020_bib34","doi-asserted-by":"crossref","first-page":"AB74","DOI":"10.4244\/EIJ-D-18-00667","article-title":"Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and BASILICA","volume":"14","author":"Dvir","year":"2018","journal-title":"EuroIntervention"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib35","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.jacc.2020.02.051","article-title":"Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction","volume":"75","author":"Landes","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2021.06.020_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jcmg.2019.06.025","article-title":"Coronary access after repeated transcatheter aortic valve implantation","volume":"13","author":"Buzzatti","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"2","key":"10.1016\/j.jcin.2021.06.020_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4244\/EIJV14I2A24","article-title":"Transcatheter aortic valve implantation: don\u2019t forget the coronary arteries!","volume":"14","author":"S\u00f8ndergaard","year":"2018","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.jcin.2021.06.020_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib39","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/CIRCULATIONAHA.118.039564","article-title":"Comparison of a complete percutaneous versus surgical approach to aortic valve replacement and revascularization in patients at intermediate surgical risk","volume":"140","author":"S\u00f8ndergaard","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jcin.2021.06.020_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008620","article-title":"Acute coronary syndrome following transcatheter aortic valve replacement","volume":"13","author":"Faroux","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.jcin.2021.06.020_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2019.06.012","article-title":"Coronary artery disease and transcatheter aortic valve replacement","volume":"74","author":"Faroux","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jcin.2021.06.020_bib42","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jcin.2017.04.034","article-title":"Frequency, timing, and impact of access-site and non-access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Piccolo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"24","key":"10.1016\/j.jcin.2021.06.020_bib43","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2021.06.020_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcin.2018.10.005","article-title":"Assessment of platelet reactivity after transcatheter aortic valve replacement","volume":"12","author":"Jimenez Diaz","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib45","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","article-title":"Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention","volume":"12","author":"Sibbing","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.06.020_bib46","unstructured":"Vavuranakis MA, Kalantzis C, Voudris V, et al. Comparison of ticagrelor versus clopidogrel on cerebrovascular microembolic events and platelet inhibition during transcatheter aortic valve implantation. Am J Cardiol Jul 6 [E-pub ahead of print]."},{"issue":"1","key":"10.1016\/j.jcin.2021.06.020_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2018.10.047","article-title":"Tailoring antiplatelet therapy in patients undergoing transcatheter aortic valve replacement","volume":"12","author":"Capodanno","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"10","key":"10.1016\/j.jcin.2021.06.020_bib48","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1055\/s-0038-1670658","article-title":"Platelet reactivity and early outcomes after transfemoral aortic valve implantation","volume":"118","author":"Gross","year":"2018","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.jcin.2021.06.020_bib49","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1055\/s-0038-1672215","article-title":"Platelet function testing after transcatheter aortic valve implantation","volume":"118","author":"Capodanno","year":"2018","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.jcin.2021.06.020_bib50","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41569-018-0049-1","article-title":"Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention","volume":"15","author":"Capodanno","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"13","key":"10.1016\/j.jcin.2021.06.020_bib51","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"3","key":"10.1016\/j.jcin.2021.06.020_bib52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (Single Antiplatelet Therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.jcin.2021.06.020_bib53","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.jcin.2021.06.020_bib54","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jcin.2021.06.020_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2021.06.020_bib56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A\u00a0controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2021.06.020_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2021.06.020_bib58","unstructured":"Collet JP. Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial. Presented at: ACC.21 Scientific Sessions. May 15, 2021; Virtual."},{"issue":"9","key":"10.1016\/j.jcin.2021.06.020_bib59","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2019.01.049","article-title":"Usefulness of clopidogrel loading in patients who underwent transcatheter aortic valve implantation (from the BRAVO-3 randomized trial)","volume":"123","author":"Nijenhuis","year":"2019","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.jcin.2021.06.020_bib60","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","volume":"42","author":"ten Berg","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jcin.2021.06.020_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2018.08.1045","article-title":"Long-term mortality and early valve dysfunction according to anticoagulation use","volume":"73","author":"Overtchouk","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib62","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jcin.2016.06.025","article-title":"Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement","volume":"9","author":"Abdul-Jawad Altisent","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib63","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jcin.2019.06.001","article-title":"Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve replacement in patients with atrial fibrillation","volume":"12","author":"Kosmidou","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"18","key":"10.1016\/j.jcin.2021.06.020_bib64","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jcin.2021.06.020_bib65","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jcin.2021.06.020_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"16","key":"10.1016\/j.jcin.2021.06.020_bib67","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jcin.2019.03.003","article-title":"Oral\u00a0anticoagulant type and outcomes after transcatheter aortic valve replacement","volume":"12","author":"Jochheim","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"1","key":"10.1016\/j.jcin.2021.06.020_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ehjcvp\/pvz064","article-title":"Vitamin K antagonists versus direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation","volume":"7","author":"Butt","year":"2021","journal-title":"Eur Hear J Cardiovasc Pharmacother"},{"issue":"22","key":"10.1016\/j.jcin.2021.06.020_bib69","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after\u00a0TAVR","volume":"13","author":"Kawashima","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"15","key":"10.1016\/j.jcin.2021.06.020_bib70","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcin.2021.05.025","article-title":"TAVR patients requiring anticoagulation: direct oral anticoagulant or vitamin K antagonist?","volume":"14","author":"Didier","year":"2021","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.06.020_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation\u2014rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"Van Mieghem","year":"2018","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879821011481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879821011481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:14:42Z","timestamp":1761848082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879821011481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":71,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1936879821011481"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2021.06.020","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy After Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2021.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}